Laser and optical imaging developer Advanced Research Technologies (ART) of Montreal and GE Medical Systems of Waukesha, WI, have closed the first sale of ART’s pre-clinical optical molecular imaging system to the U.S. National Institutes of Health. The small animal molecular imager (SAMI) product has been on the commercial market for three months is exclusively distributed worldwide by GE.
By AuntMinnie.com staff writersSeptember 23, 2003
Related Reading
ART starts clinical trials, September 19, 2003
GE expands ART relationship, August 14, 2003
FDA clears mobile version of GE’s Discovery ST PET/CT, March 31, 2003
GE inks deal with optical imaging firm, October 25, 2002
ART appoints Huot as CEO, September 14, 2001
Copyright © 2003 AuntMinnie.com
